RRNMF Neuromuscular Journal最新文献_第9页

RRNMF Neuromuscular Journal Pub Date : 2022-06-22 DOI: 10.17161/rrnmf.v3i2.17030

H. Gibson

引用次数: 0

Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy 使用自适应平台确定隐源性感觉多发性神经病的最佳或劣质药物

RRNMF Neuromuscular Journal Pub Date : 2022-06-22 DOI: 10.17161/rrnmf.v3i2.18133

R. Barohn, J. Allen, D. Avila, A. Barboi, S. Biliciler, C. Abrams, Thomas Brannagan III, Michael Cartwright, N. Chahin, J. Chawla, Miguel Chuquilin, Michael Collins, A. Deboo, J. England, J. Fernandes, M. Friemer, S. Geisler, S. Herskovitz, N. Holland, Carlayne Jackson, V. Juel, D. Lacomis, Maxwell H Levy, Rabia N. Malik, D. Menichella, S. Nations, A. Peltier, M. Pulley, K. Rezania, J. Robinson-Papp, Katherine Ruzhansky, K. Sharma, A. Stino, Xiaowei W Su, A. Swenson, P. Thaisetthawatkul, S. Thawani, Rebecca E. Traub

引用次数: 1

Boots 靴子

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v2i5.15966

Michael Stanley

引用次数: 0

A rare paraneoplastic syndrome causing weakness, pain and low serum phosphorous 一种罕见的副肿瘤综合征，引起虚弱、疼痛和低血清磷

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v3i1.15850

J. Elliott

引用次数: 0

Screening for depression in myasthenia gravis 重症肌无力患者抑郁的筛查

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v3i1.15536

Bakri H. Elsheikh, Obinna Moneme, M. Freimer, J. Kissel, W. Arnold

{"title":"Screening for depression in myasthenia gravis","authors":"Bakri H. Elsheikh, Obinna Moneme, M. Freimer, J. Kissel, W. Arnold","doi":"10.17161/rrnmf.v3i1.15536","DOIUrl":"https://doi.org/10.17161/rrnmf.v3i1.15536","url":null,"abstract":"Introduction: There are conflicting reports of depression prevalence in myasthenia gravis (MG). The influence of somatic symptoms on screening assessments is not apparent. We investigated the frequency of somatic and non-somatic symptoms of depression in MG. We also explored the relationship between depression and MG using disease severity and quality of life measures. Methods: Three cohorts of participants (MG, healthy and disease controls) were prospectively assessed with the Beck Depression Inventory 2 (BDI-II) and BDI-Primary Care (BDI-PC) surveys, modified Rankin Scale, MGFA classification, MG-MMT, MG-ADL and MG-QOL15. Results: A total of 31 MG, 29 disease controls, and 30 healthy controls were enrolled. Depression frequency indicated by BDI-II in MG 48% (15/31) and disease control 31% (9/29) was not significantly different [p=0.17]. However, we found a significantly higher frequency than healthy controls 10% (3/30) [p=0.001]. In contrast, depression frequency indicated by BDI-PC was similar in the MG 29% (9/31) and disease controls MG, 24% (7/29)[p=0.77] as well as the healthy controls 10% (3/30) [p=0.08]. \u0000Using the BDI-II scale, participants with MG who were depressed had higher scores on MG-MMT, MG-ADL, and MG-QOL15 than those who were not depressed. The difference in MG-ADL and MG-QOL15 scores remained significant using the BDI-PC score. Discussion: These findings suggest depression screening assessments that include physical symptoms overestimate depression in MG and chronic autoimmune neuromuscular disorders. A higher frequency of self-reported depression is associated with increasing disease severity and low quality of life.","PeriodicalId":309700,"journal":{"name":"RRNMF Neuromuscular Journal","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123538670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Guillain-Barre Syndrome Secondary to COVID-19: A case report and short review of other published cases COVID-19继发格林-巴利综合征:病例报告和其他已发表病例的简短回顾

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v3i1.15770

Mukaish Kumar, B. Banik, R. Govindarajan

{"title":"Guillain-Barre Syndrome Secondary to COVID-19: A case report and short review of other published cases","authors":"Mukaish Kumar, B. Banik, R. Govindarajan","doi":"10.17161/rrnmf.v3i1.15770","DOIUrl":"https://doi.org/10.17161/rrnmf.v3i1.15770","url":null,"abstract":"Background: \u0000COVID-19 related Guillain-Barré syndrome has a broad spectrum of presentation. In most reported cases, respiratory symptoms preceded by neurological deficits by one to two weeks, suggesting that the clinical course is mostly post-infectious. In this case report, we present a para-infectious case of GBS with COVID-19. \u0000Case presentation: \u0000A 37-year-old male patient presented with fever, chills, myalgia, cough, and anosmia. COVID-19 test came positive. He was managed conservatively. On the 7th day of follow-up, he recovered except for a persistent loss of smell and taste. Two weeks after his initial presentation, he reported low back pain and bilateral lower extremity weakness and had a repeat COVID-19 test, which returned positive. His history, physical exam, CSF analysis, nerve conduction, and electromyography test revealed Guillain-Barre Syndrome. We managed GBS with supportive treatment in the hospital, and on follow-up of three months, he recovered fully. \u0000Conclusion: \u0000In our case, we report a para-infectious case of GBS with C0VID-19, and we managed this case without intravenous immunoglobulin or plasmapheresis. The decision to treat a COVID-19 related GBS case with a traditional GBS treatment option (intravenous immunoglobulin or plasmapheresis) should be taken in conjunction with co-morbidities and a tailored case of case basis.","PeriodicalId":309700,"journal":{"name":"RRNMF Neuromuscular Journal","volume":"90 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121387428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Brooklyn Nostalgia 布鲁克林怀旧

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v3i1.15841

Joshua Freeman

引用次数: 0

EE2: 3,4-Diaminopyridine Phosphate for AAL- The EEDAPP-ALS Trial EE2: 3,4-磷酸二氨基吡啶用于AAL- EEDAPP-ALS试验

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v3i1.16747

R. Govindarajan, S. Iyadurai, Alex Karenevich, L. Herbelin, J. Statland, R. Barohn

引用次数: 0

Time Heals All Wounds-But One 时间能治愈一切创伤，但只有一个例外

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v3i1.15924

Vernon D. Rowe

引用次数: 0

Poems 诗

RRNMF Neuromuscular Journal Pub Date : 2022-03-11 DOI: 10.17161/rrnmf.v3i1.15922

E. Rowe

引用次数: 0